59660-95-6Relevant articles and documents
From benzimidazole to indole-5-carboxamide Thumb Pocket I inhibitors of HCV NS5B polymerase. Part 1: Indole C-2 SAR and discovery of diamide derivatives with nanomolar potency in cell-based subgenomic replicons
Beaulieu, Pierre L.,Gillard, James,Jolicoeur, Eric,Duan, Jianmin,Garneau, Michel,Kukolj, George,Poupart, Marc-Andre
, p. 3658 - 3663 (2011)
Replacement of the benzimidazole core of allosteric Thumb Pocket 1 HCV NS5B finger loop inhibitors by more lipophilic indole derivatives provided up to 30-fold potency improvements in cell-based subgenomic replicon assays. Optimization of C-2 substitution on the indole core led to the identification of analogs with EC50 100 nM and modulated the pharmacokinetic properties of the inhibitors based on preliminary data from in vitro ADME profiles and in vivo rat PK.
Phosphatidylinositol 3-Kinase Inhibitors for the Treatment of Lymphoproliferative Malignancies
-
Paragraph 0086; 0154; 0158, (2017/11/07)
Methods are provided for treating a lymphoproliferative malignancy to a patient in need of such treatment, comprising administering to the patient an effective amount of compound A as described herein.
TABLET FORMULATION OF A PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR
-
Page/Page column 24; 25, (2014/04/03)
Methods are provided for treating cancer to a patient in need of such treatment, comprising administering a PI3K inhibitor.